Chargement en cours...
Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer
Lung cancer remains the leading cause of cancer-related death in men and women, despite its constantly declining rates in incidence and mortality in the developed world. The past decade has witnessed an unprecedented rise in the development of molecular targeted therapies in various types of tumors....
Enregistré dans:
| Publié dans: | Ann Transl Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AME Publishing Company
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952024/ https://ncbi.nlm.nih.gov/pubmed/29862231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.04.28 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|